CIK 2005245
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 90.73% | 64 |
| Unclassified | 3.10% | 6 |
| Software | 1.67% | 9 |
| Software & IT Services | 1.52% | 3 |
| Semiconductors & Semiconductor Equipment | 1.01% | 4 |
| Commercial Services & Supplies | 0.91% | 2 |
| Specialty Retail | 0.27% | 1 |
| Life Sciences Tools & Services | 0.26% | 2 |
| Automobiles & Components | 0.26% | 2 |
| Electrical Equipment & Components | 0.08% | 1 |
| Banks | 0.05% | 2 |
| Textiles, Apparel & Luxury Goods | 0.05% | 1 |
| Real Estate Management & Development | 0.04% | 1 |
| Health Care Equipment & Supplies | 0.03% | 1 |
| Beverages | 0.03% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | SRRK | Scholar Rock Holding Corp | Health Care | 14.75% |
| 2 | KYMR | Kymera Therapeutics, Inc. | Health Care | 7.36% |
| 3 | ERAS | Erasca, Inc. | Health Care | 5.04% |
| 4 | EWTX | Edgewise Therapeutics, Inc. | Health Care | 3.87% |
| 5 | ONC | BeOne Medicines Ltd. | Health Care | 3.83% |
| 6 | TNGX | Tango Therapeutics, Inc. | Health Care | 3.28% |
| 7 | BCAX | Bicara Therapeutics Inc. | Health Care | 3.20% |
| 8 | RVMD | Revolution Medicines, Inc. | Health Care | 3.00% |
| 9 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Health Care | 2.81% |
| 10 | MANE | Veradermics, Inc | Health Care | 2.64% |
94/100 names classified · sector 96.9% of weight · industry 96.9% · mkt cap 95.6%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 96.9% of the book is sector-classified (unclassified names shown, never dropped).
Only 8% of book weight classified — the grid is NOT representative of the whole book.
Classified: 8.2% of book weight (15/99 names) · unclassified 91.8%: SRRK, KYMR, ERAS, EWTX, TNGX, BCAX, RVMD, ARWR, MANE, +74 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | SRRKSCHOLAR ROCK HLDG CORP | 10,825,013 | $532M | 14.8% | HOLD |
| 2 | KYMRKYMERA THERAPEUTICS INC | 3,186,830 | $265M | 7.4% | TRIM −3% |
| 3 | ERASERASCA INC | 11,244,246 | $182M | 5.0% | ADD 28% |
| 4 | EWTXEDGEWISE THERAPEUTICS INC | 4,430,263 | $140M | 3.9% | TRIM −2% |
| 5 | ONCBEONE MEDICINES LTD | 465,000 | $138M | 3.8% | TRIM −7% |
| 6 | TNGXTANGO THERAPEUTICS INC | 5,657,105 | $118M | 3.3% | TRIM −31% |
| 7 | BCAXBICARA THERAPEUTICS INC | 5,802,970 | $115M | 3.2% | ADD 11% |
| 8 | RVMDREVOLUTION MEDICINES INC | 1,110,980 | $108M | 3.0% | TRIM −17% |
| 9 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,615,476 | $101M | 2.8% | ADD 8% |
| 10 | MANEVeradermics Inc | 1,505,374 | $95M | 2.6% | NEW |
| 11 | XENEXENON PHARMACEUTICALS INC | 1,318,564 | $77M | 2.1% | ADD 62% |
| 12 | OLMAOLEMA PHARMACEUTICALS INC | 4,756,949 | $71M | 2.0% | ADD 44% |
| 13 | CRNXCRINETICS PHARMACEUTICALS IN | 1,903,636 | $69M | 1.9% | ADD 26% |
| 14 | LXRXLEXICON PHARMACEUTICALS INC | 44,303,518 | $69M | 1.9% | ADD 14% |
| 15 | COGTCOGENT BIOSCIENCES INC | 1,709,279 | $66M | 1.8% | ADD 5% |
| 16 | STOKSTOKE THERAPEUTICS INC | 1,995,347 | $65M | 1.8% | TRIM −11% |
| 17 | RCUSARCUS BIOSCIENCES INC | 3,007,077 | $65M | 1.8% | HOLD |
| 18 | GPCRSTRUCTURE THERAPEUTICS INC | 1,328,698 | $64M | 1.8% | ADD 23% |
| 19 | IRONDISC MEDICINE INC | 988,401 | $63M | 1.8% | HOLD |
| 20 | RYTMRHYTHM PHARMACEUTICALS INC | 725,511 | $63M | 1.7% | ADD 45% |
| 21 | SLDBSOLID BIOSCIENCES INC | 7,690,405 | $55M | 1.5% | HOLD |
| 22 | SEPNSEPTERNA INC | 2,000,000 | $48M | 1.3% | HOLD |
| 23 | CENTESSA PHARMACEUTICALS PLC | 1,053,464 | $42M | 1.2% | TRIM −74% |
| 24 | SYRESPYRE THERAPEUTICS INC | 818,598 | $41M | 1.1% | HOLD |
| 25 | CYTKCYTOKINETICS INC | 613,952 | $40M | 1.1% | NEW |
| 26 | DYNDYNE THERAPEUTICS INC | 2,229,125 | $40M | 1.1% | TRIM −36% |
| 27 | TSHATAYSHA GENE THERAPIES INC | 8,829,913 | $39M | 1.1% | TRIM −13% |
| 28 | DBVTDBV TECHNOLOGIES S A | 1,857,362 | $39M | 1.1% | HOLD |
| 29 | ORICORIC PHARMACEUTICALS INC | 2,998,192 | $38M | 1.1% | ADD 198% |
| 30 | ENGENE HOLDINGS INC | 5,253,159 | $36M | 1.0% | ADD 57% |
| 31 | PVLAPALVELLA THERAPEUTICS INC | 257,485 | $32M | 0.9% | ADD 243% |
| 32 | TBLATABOOLA.COM LTD | 9,969,495 | $31M | 0.9% | HOLD |
| 33 | ELVNENLIVEN THERAPEUTICS INC | 746,226 | $29M | 0.8% | NEW |
| 34 | DNLIDENALI THERAPEUTICS INC | 1,396,513 | $27M | 0.7% | HOLD |
| 35 | RELYREMITLY GLOBAL INC | 1,543,271 | $24M | 0.7% | TRIM −5% |
| 36 | DMRADAMORA THERAPEUTICS INC | 900,000 | $23M | 0.6% | NEW |
| 37 | ZURAZURA BIO LTD | 3,734,866 | $22M | 0.6% | ADD 187% |
| 38 | ANNXANNEXON INC | 3,958,646 | $22M | 0.6% | NEW |
| 39 | TRVITREVI THERAPEUTICS INC | 1,786,867 | $21M | 0.6% | TRIM −22% |
| 40 | RAPPRAPPORT THERAPEUTICS INC | 641,469 | $20M | 0.6% | TRIM −9% |
| 41 | GOOGLALPHABET INC | 65,703 | $19M | 0.5% | ADD 217% |
| 42 | FULCFULCRUM THERAPEUTICS INC | 2,350,000 | $18M | 0.5% | ADD 21% |
| 43 | WVEWAVE LIFE SCIENCES LTD | 2,450,000 | $18M | 0.5% | HOLD |
| 44 | DFTXDEFINIUM THERAPEUTICS INC COM SHS | 919,493 | $17M | 0.5% | NEW |
| 45 | AMLXAMYLYX PHARMACEUTICALS INC | 1,230,000 | $17M | 0.5% | NEW |
| 46 | CGEMCULLINAN THERAPEUTICS INC | 1,193,410 | $17M | 0.5% | HOLD |
| 47 | NMRANEUMORA THERAPEUTICS INC. | 8,497,822 | $17M | 0.5% | ADD 35% |
| 48 | QUREUNIQURE NV | 1,000,000 | $16M | 0.5% | NEW |
| 49 | CTMXCYTOMX THERAPEUTICS INC. | 3,457,711 | $16M | 0.5% | NEW |
| 50 | NVDANVIDIA CORPORATION | 89,085 | $16M | 0.4% | ADD 138% |
| 51 | SLNSILENCE THERAPEUTICS PLC | 2,911,438 | $15M | 0.4% | HOLD |
| 52 | MSFTMICROSOFT CORP | 41,380 | $15M | 0.4% | ADD 176% |
| 53 | MNPRMONOPAR THERAPEUTICS INC | 270,118 | $15M | 0.4% | ADD 27% |
| 54 | TSMTAIWAN SEMICONDUCTOR MFG LTD | 42,200 | $14M | 0.4% | ADD 52% |
| 55 | SIONSIONNA THERAPEUTICS INC | 300,000 | $12M | 0.3% | HOLD |
| 56 | NBISNEBIUS GROUP N.V. | 113,614 | $12M | 0.3% | ADD 49% |
| 57 | RZLTREZOLUTE INC | 3,328,287 | $10M | 0.3% | NEW |
| 58 | IKTINHIBIKASE THERAPEUTICS INC | 5,850,000 | $10M | 0.3% | HOLD |
| 59 | AMZNAMAZON COM INC | 46,641 | $10M | 0.3% | TRIM −9% |
| 60 | GENBGENERATE BIOMEDICINES INC | 736,104 | $9M | 0.3% | NEW |
| 61 | MPLTMAPLIGHT THERAPEUTICS INC | 450,000 | $9M | 0.3% | HOLD |
| 62 | NOWSERVICENOW INC | 87,090 | $9M | 0.3% | ADD 144% |
| 63 | CRWDCROWDSTRIKE HLDGS INC | 23,070 | $9M | 0.2% | ADD 40% |
| 64 | PDDPDD HOLDINGS INC | 83,401 | $9M | 0.2% | ADD 32% |
| 65 | TSLATESLA INC | 21,500 | $8M | 0.2% | ADD 1333% |
| 66 | NBPNOVABRIDGE BIOSCIENCES | 3,000,000 | $7M | 0.2% | HOLD |
| 67 | BCYCBICYCLE THERAPEUTICS PLC | 1,560,882 | $7M | 0.2% | TRIM −22% |
| 68 | WHWKWHITEHAWK THERAPEUTICS INC | 2,082,000 | $7M | 0.2% | HOLD |
| 69 | TENXTENAX THERAPEUTICS INC | 427,141 | $7M | 0.2% | HOLD |
| 70 | VTVTVTV THERAPEUTICS INC | 163,000 | $6M | 0.2% | HOLD |
| 71 | DDOGDATADOG INC | 54,300 | $6M | 0.2% | ADD 49% |
| 72 | FROGJFROG LTD | 128,816 | $6M | 0.2% | ADD 38% |
| 73 | DTDYNATRACE INC | 150,000 | $6M | 0.2% | ADD 30% |
| 74 | WKWORKIVA INC | 92,500 | $6M | 0.2% | ADD 17% |
| 75 | ABSIABSCI CORPORATION | 1,800,000 | $5M | 0.1% | NEW |
| 76 | IVVDINVIVYD INC | 4,000,000 | $5M | 0.1% | HOLD |
| 77 | MSLESATELLOS BIOSCIENCE INC | 892,074 | $5M | 0.1% | NEW |
| 78 | IONQIONQ INC | 170,000 | $5M | 0.1% | HOLD |
| 79 | AVGOBROADCOM INC | 15,000 | $5M | 0.1% | ADD 114% |
| 80 | AGMBAGOMAB THERAPEUTICS NV | 411,250 | $4M | 0.1% | NEW |
| 81 | CLBTCELLEBRITE DI LTD | 311,544 | $4M | 0.1% | ADD 108% |
| 82 | SEERSEER INC | 2,458,673 | $4M | 0.1% | TRIM −39% |
| 83 | KRROKORRO BIO INC | 347,718 | $4M | 0.1% | HOLD |
| 84 | AGENAGENUS INC | 1,064,250 | $4M | 0.1% | HOLD |
| 85 | FHTXFOGHORN THERAPEUTICS INC | 720,720 | $3M | 0.1% | HOLD |
| 86 | FPSForgent Power Solutions Inc | 100,000 | $3M | 0.1% | NEW |
| 87 | KLRSKALARIS THERAPEUTICS INC | 435,798 | $3M | 0.1% | HOLD |
| 88 | GTLBGITLAB INC | 100,000 | $2M | 0.1% | HOLD |
| 89 | MUMICRON TECHNOLOGY INC | 6,000 | $2M | 0.1% | NEW |
| 90 | MNDYMONDAY COM LTD | 25,000 | $2M | 0.0% | ADD 47% |
| 91 | GOSSGOSSAMER BIO INC | 5,208,968 | $2M | 0.0% | HOLD |
| 92 | ASAMER SPORTS INC | 50,000 | $2M | 0.0% | NEW |
| 93 | BEKEKE HLDGS INC | 100,000 | $1M | 0.0% | TRIM −31% |
| 94 | IRENIREN LIMITED | 43,100 | $1M | 0.0% | HOLD |
| 95 | RANIRANI THERAPEUTICS HLDGS INC | 2,000,000 | $1M | 0.0% | HOLD |
| 96 | AEVAAEVA TECHNOLOGIES INC | 110,000 | $1M | 0.0% | NEW |
| 97 | MDLNMEDLINE INC | 25,000 | $1M | 0.0% | TRIM −67% |
| 98 | FIGFIGMA INC | 50,000 | $1M | 0.0% | ADD 100% |
| 99 | PRMBPRIMO BRANDS CORPORATION | 50,000 | $941,500 | 0.0% | TRIM −33% |
| 100 | NUNU HLDGS LTD | 25,000 | $359,250 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| SRRKSCHOLAR ROCK HLDG CORP | 9.3M | 9.3M | 9.3M | 9.3M | 10.8M | 10.8M | $532M |
| KYMRKYMERA THERAPEUTICS INC | 3.0M | 3.2M | 3.4M | 3.4M | 3.3M | 3.2M | $265M |
| ERASERASCA INC | 8.9M | 8.8M | 8.8M | 8.8M | 8.8M | 11.2M | $182M |
| EWTXEDGEWISE THERAPEUTICS INC | 734K | 1.7M | 3.2M | 3.9M | 4.5M | 4.4M | $140M |
| ONCBEONE MEDICINES LTD | 654K | 499K | 510K | 493K | 500K | 465K | $138M |
| TNGXTANGO THERAPEUTICS INC | 2.6M | 2.6M | 3.4M | 5.9M | 8.2M | 5.7M | $118M |
| BCAXBICARA THERAPEUTICS INC | 3.3M | 3.3M | 5.2M | 5.2M | 5.2M | 5.8M | $115M |
| RVMDREVOLUTION MEDICINES INC | 572K | 564K | 939K | 1.0M | 1.3M | 1.1M | $108M |
| ARWRARROWHEAD PHARMACEUTICALS IN | 2.9M | 2.7M | 2.7M | 2.7M | 1.5M | 1.6M | $101M |
| MANEVeradermics Inc | — | — | — | — | — | 1.5M | $95M |
| XENEXENON PHARMACEUTICALS INC | 744K | 733K | 813K | 813K | 813K | 1.3M | $77M |
| OLMAOLEMA PHARMACEUTICALS INC | — | — | — | — | 3.3M | 4.8M | $71M |
| CRNXCRINETICS PHARMACEUTICALS IN | 1.6M | 1.7M | 1.7M | 1.7M | 1.5M | 1.9M | $69M |
| LXRXLEXICON PHARMACEUTICALS INC | 38.9M | 38.9M | 38.9M | 38.9M | 38.9M | 44.3M | $69M |
| COGTCOGENT BIOSCIENCES INC | — | — | 854K | 1.7M | 1.6M | 1.7M | $66M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
